Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for WUXIF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for WUXIF and 80,000+ other tickers.
See exactly how WUXIF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for WUXIF and 80,000+ other tickers.
WuXi AppTec Co., Ltd., an investment holding firm, specializes in providing a full spectrum of research, development, and manufacturing services. The company's expertise is leveraged globally to facilitate the discovery, advancement, and production of both small molecule pharmaceuticals and innovative cell and gene therapies. Its operational reach extends throughout the People's Republic of China, across the broader Asian continent, within the United States, and across Europe. The organization is structured into six distinct divisions: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU…
Sotera Health (NASDAQ: SHC - Get Free Report) and WuXi AppTec (OTCMKTS:WUXIF - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings. Insider and Institutional Ownership 91.0% of Sotera Health
WuXi AppTec said on Thursday that it has filed a complaint at the United States District Court for the District of Columbia against the Department of Defense for including the company in a list linked to the Chinese military.
SHANGHAI, May 17, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has been selected for the 2026 Dow Jones Best-in-Class World Index (DJ BIC World Index, formerly Dow Jones Sustainability World Index), which recognizes the top-performing companies in each industry on long-term sustainability criteria. This recognition reflects progress that WuXi AppTec has made in integrating responsible sustainability practices across its operations and strategies.
WuXi AppTec Co., Ltd. (WUXAY) Q4 2025 Earnings Call Transcript
WuXi AppTec Co., Ltd. (WUXAY) Presents at 44th Annual J.P.